HOME >> BIOLOGY >> NEWS
Mice with hyperactive Wnt10b gene eat all they want, but have half the body fat of normal mice

Wnt10b transgenic mice had half as much adipose tissue and produced half the normal amount of leptin, they had none of the metabolic consequences we expected," MacDougald says. "In fact, the insulin sensitivity and glucose tolerance of transgenic mice on a high-fat diet was better than that of normal mice on a low-fat diet. We don't know why, but additional research should provide some answers."

Currently, researchers in MacDougald's lab are studying the effect of Wnt proteins on mice with genetically induced obesity. They also plan to explore the effect of Wnt signaling on the development of osteoblasts, the bone-forming cells in marrow.

But don't look for Wnt10b diet pills to be on the market any time soon, cautions Longo and MacDougald.

"Pharmaceutical companies are interested in the potential therapeutic role of Wnt genes in decreasing fatty tissue, but finding the right drug to selectively target this pathway without complications will be a considerable challenge," MacDougald says. "The goal of our research is to learn how fat cell development is regulated, but this work may also improve our understanding of obesity and its complications."

"We've seen the potent effect of Wnt10b on fat in mice, but we don't know if it would work the same way in humans," Longo adds. "And, if the results we see in the skin of the transgenic mice are any indication, I'd say we have to tread carefully. I think we'd all like to be thicker-skinned, but only in the figurative sense."


'"/>


28-Jun-2004


Page: 1 2 3

Related biology news :

1. Cytokine signal shuts down hyperactive T cells
2. Protein is key to fatal disorder and normal cell function
3. Screen siblings, parents of infants with severe heart abnormalities
4. LBP-1a gene mutation linked to disruption of normal fetal development
5. Method to visualize gene activity may provide insight into normal development & genome function
6. Common therapy for HIV associated with cervical abnormality regression
7. Why does cloning create abnormalities? Scientists take a step towards finding out
8. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
9. Abnormal chromosomes forecast leukemia relapse
10. Malignant breast cancer cells to revert to normal with manipulation
11. Gene essential for development of normal brain connections resulting from sensory input discovered

Post Your Comments:
(Date:5/24/2013)... New Orleans, LA After studying noise in one ... or not noise levels exceeded municipal ordinances, Annette Hurley, ... Center New Orleans, and Eric Arriaga, a third-year LSUHSC ... technology to protect their own hearing health. Their case ... Advance for Hearing Practice Management ., "An important ...
(Date:5/23/2013)... fruit, can be made both better-tasting and longer-lasting thanks ... "Working with GM tomatoes that are different to normal ... allows us to pinpoint exactly how to breed in ... Innes Centre. , The research could also lead to ... characteristics because even higher levels of the compounds can ...
(Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...
Breaking Biology News(10 mins):Please do try this at home 2The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
(Date:5/23/2013)... Colo. , May 23, 2013 Venaxis, ... diagnostic company focused on obtaining FDA clearance and commercializing ... today announced the pricing of an underwritten public offering ... warrants to purchase 3,500,000 shares of its common stock ... a combined public offering price of $1.25 per share ...
(Date:5/23/2013)... , May 23, 2013 PuraMed ... developer, and marketer of over-the-counter (OTC) medicinal and ... research opinion on the company based on low ... , Non-Prescription, All Natural Product to Treat ... Product Outperforms #1 Prescription Competitor , Currently ...
(Date:5/23/2013)... LAGUNA HILLS, Calif. , May 23, 2013 /PRNewswire-USNewswire/ ... CA recently became the first hospital on ... site robotic technology. This new surgical option provides women ... Marc Winter , ... gynecologist and surgeon and medical director of minimally ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
Cached News: